β-D-Glucopyranosiduronic acid, 5-bromo-4-chloro-1H-indol-3-yl, sodium salt (1:1) – (129541-41-9)

114162-64-0, X-Gluc (cyclohexanamine), X-Beta-d-glcua dcha h2o, Cyclohexanamine (2S, 3S, 4S, 5R, 6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-carboxylate, 5-Bromo-4-chloro-3-indolyl beta-D-glucuronide cyclohexylammonium salt, 5-BROMO-4-CHLORO-3-INDOLYL B-D-, (2S, 3S, 4S, 5R, 6S)-6-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-3, 4, 5-trihydroxyoxane-2-carboxylic acid cyclohexanamine, 5-Bromo-4-chloro-3-indolyl-beta-D-glucuronide cyclohexylammonium salt, 5-Bromo-4-chloro-3-indolyl Beta-D-glucuronide, Cyclohexylammonium Salt, ss-D-Glucopyranosiduronic acid, 5-bromo-4-chloro-1H-indol-3-yl, compd. with cyclohexanamine (1:1) X-Gluc 5-Bromo-4-chloro-3-indolyl ss-D-glucuronide Cyclohexylammonium Salt, XGLUC Cyclohexylammonium Salt, X-GLUC CYCLOHEXYLAMINE, SCHEMBL1254607, DTXSID10921292, JXCKZXHCJOVIAV-CYRSAHDMSA-N, HY-15935B, 5-Bromo-4-chloro-3-indolyl b-D-glucuronide cyclohexylammonium salt monohydrate, AKOS022186527, EB04274, (2S, 3S, 4S, 5R, 6S)-6-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-3, 4, 5-trihydroxyoxane-2-carboxylic acid cyclohexanamine, AC-24655, AS-74628, Cyclohexanamine(2S, 3S, 4S, 5R, 6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-carboxylate, PD165827, CS-0019449, X-GlcA, reagent for selection of recombinant bacterial clones, 5-Bromo-4-chloro-3-indolyl b-D-glucuronide, Cyclohexylammonium Salt, 5-Bromo-4-chloro-3-indolyl beta-D-glucuronic acid cyclohexylammonium salt, 5-Bromo-4-chloro-3-indolyl beta-D-glucuronide cyclohexylammonium salt, tablet, X-Glucuronide X-GlcA X-beta-D-glucuronide cyclohexylammonium salt X-beta-D-GlcA CHX salt, .beta.-D-Glucopyranosiduronic acid, 5-bromo-4-chloro-1H-indol-3-yl, compd. with cyclohexanamine (1:1), 601-302-0